M Steger

580 total citations
8 papers, 477 citations indexed

About

M Steger is a scholar working on Obstetrics and Gynecology, Surgery and Molecular Biology. According to data from OpenAlex, M Steger has authored 8 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Obstetrics and Gynecology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in M Steger's work include Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Cancer therapeutics and mechanisms (2 papers). M Steger is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Cancer therapeutics and mechanisms (2 papers). M Steger collaborates with scholars based in United States, Germany and Brazil. M Steger's co-authors include Claire F. Verschraegen, Andrzej P. Kudelka, Ralph S. Freedman, J. J. Kavanagh, D G Kieback, John J. Kavanagh, Tally Levy, Creighton L. Edwards, E. Neely Atkinson and F. Majewski and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and European Journal of Pediatrics.

In The Last Decade

M Steger

8 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Steger United States	7	217	206	139	124	113	8	477
Gun Yoon South Korea	13	91 0.4×	177 0.9×	82 0.6×	143 1.2×	115 1.0×	39	489
K. Oliva Australia	8	164 0.8×	120 0.6×	46 0.3×	80 0.6×	78 0.7×	13	431
Shizuo Machida Japan	13	117 0.5×	136 0.7×	163 1.2×	120 1.0×	46 0.4×	30	466
Mian He China	10	174 0.8×	175 0.8×	44 0.3×	79 0.6×	80 0.7×	21	472
A. Graf Austria	17	197 0.9×	80 0.4×	422 3.0×	321 2.6×	219 1.9×	30	826
C Villena-Heinsen Germany	14	132 0.6×	124 0.6×	88 0.6×	79 0.6×	55 0.5×	51	490
Daniel Patterson United Kingdom	10	94 0.4×	121 0.6×	120 0.9×	27 0.2×	135 1.2×	17	644
N. Sakuragi Japan	11	81 0.4×	79 0.4×	216 1.6×	183 1.5×	56 0.5×	28	423
Domenico Ferraioli France	10	135 0.6×	117 0.6×	87 0.6×	80 0.6×	58 0.5×	27	314
Liangdan Tang China	15	61 0.3×	220 1.1×	193 1.4×	168 1.4×	66 0.6×	35	524

Countries citing papers authored by M Steger

Since Specialization

Citations

This map shows the geographic impact of M Steger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Steger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Steger more than expected).

Fields of papers citing papers by M Steger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Steger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Steger. The network helps show where M Steger may publish in the future.

Co-authorship network of co-authors of M Steger

This figure shows the co-authorship network connecting the top 25 collaborators of M Steger. A scholar is included among the top collaborators of M Steger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Steger. M Steger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Verschraegen, Claire F., Wei Hu, Evelyne M. Loyer, et al.. (2003). Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. Gynecologic Oncology. 90(3). 552–559. 37 indexed citations

2.

Verschraegen, Claire F., et al.. (2000). Docetaxel for Patients With Paclitaxel-Resistant Müllerian Carcinoma. Journal of Clinical Oncology. 18(14). 2733–2739. 108 indexed citations

3.

Verschraegen, Claire F., Elora Gupta, Evelyne M. Loyer, et al.. (1999). A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer. Anti-Cancer Drugs. 10(4). 375–384. 55 indexed citations

4.

Verschraegen, Claire F., Tally Levy, Andrzej P. Kudelka, et al.. (1997). Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.. Journal of Clinical Oncology. 15(2). 625–631. 104 indexed citations

5.

Kudelka, A P, Tally Levy, Claire F. Verschraegen, et al.. (1997). A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.. PubMed. 3(9). 1501–5. 108 indexed citations

6.

Kudelka, Andrzej P., Claire F. Verschraegen, Tally Levy, et al.. (1996). Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix. Anti-Cancer Drugs. 7(4). 398–401. 18 indexed citations

7.

Majewski, F. & M Steger. (1984). Fetal head growth retardation associated with maternal phenobarbitone/primidone and/or phenytoin therapy. European Journal of Pediatrics. 141(3). 188–189. 5 indexed citations

8.

Majewski, F., et al.. (1981). The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents.. PubMed. 2(1). 37–45. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact